Clinical Trial Detail

NCT ID NCT02790515
Title Provision of TCR?? T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation
Recruitment Recruiting
Gender
Phase Phase II
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

juvenile myelomonocytic leukemia

chronic myeloid leukemia

myeloid sarcoma

myelodysplastic syndrome

non-Hodgkin lymphoma

acute lymphoblastic leukemia

acute myeloid leukemia

Therapies

Sirolimus

anti-thymocyte globulin

Blinatumomab

Tacrolimus

Thiotepa

Melphalan

Fludarabine

Cyclophosphamide

Mesna

Rituximab

Filgrastim

Age Groups: adult child

No variant requirements are available.